US BANCORP \DE\ - ASCENDIS PHARMA A/S ownership

ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 168 filers reported holding ASCENDIS PHARMA A/S in Q1 2023. The put-call ratio across all filers is 0.19 and the average weighting 0.6%.

Quarter-by-quarter ownership
US BANCORP \DE\ ownership history of ASCENDIS PHARMA A/S
ValueSharesWeighting
Q3 2023$19,665
+36.0%
210
+29.6%
0.00%
Q2 2023$14,459
-87.3%
162
-84.8%
0.00%
Q1 2023$113,975
-22.7%
1,063
-12.0%
0.00%
Q4 2022$147,533
+13.5%
1,208
-3.6%
0.00%
Q3 2022$130,000
+44.4%
1,253
+29.2%
0.00%
Q2 2022$90,000
+25.0%
970
+58.2%
0.00%
Q1 2022$72,000
-28.7%
613
-18.8%
0.00%
Q4 2021$101,000
-30.8%
755
-17.8%
0.00%
Q3 2021$146,000
+47.5%
919
+22.0%
0.00%
Q2 2021$99,000
-6.6%
753
-7.7%
0.00%
Q1 2021$106,000
-4.5%
816
+23.1%
0.00%
Q4 2020$111,000
+9.9%
663
+1.7%
0.00%
Q3 2020$101,000
-31.8%
652
-35.0%
0.00%
Q2 2020$148,000
+117.6%
1,003
+66.6%
0.00%
Q1 2020$68,000
+28.3%
602
+56.4%
0.00%
Q4 2019$53,000
+231.2%
385
+129.2%
0.00%
Q3 2019$16,000
-5.9%
168
+14.3%
0.00%
Q2 2019$17,000
+13.3%
147
+12.2%
0.00%
Q1 2019$15,000
+200.0%
131
+72.4%
0.00%
Q4 2018$5,0000.0%760.0%0.00%
Q3 2018$5,0000.0%760.0%0.00%
Q2 2018$5,0000.0%760.0%0.00%
Q1 2018$5,000
+66.7%
760.0%0.00%
Q4 2017$3,0000.0%760.0%0.00%
Q3 2017$3,000
+50.0%
760.0%0.00%
Q2 2017$2,0000.0%760.0%0.00%
Q1 2017$2,0000.0%760.0%0.00%
Q4 2016$2,000760.00%
Other shareholders
ASCENDIS PHARMA A/S shareholders Q1 2023
NameSharesValueWeighting ↓
RA Capital Management 11,225,357$1,001,863,11218.92%
Q Global Advisors, LLC 195,000$17,40412.55%
Sofinnova Investments, Inc. 754,032$67,297,3564.41%
Avoro Capital Advisors LLC 3,580,555$319,564,5344.34%
Finepoint Capital LP 139,772$12,474,6514.32%
Spyglass Capital Management LLC 657,853$58,713,3804.24%
Saturn V Capital Management LP 78,442$7,000,9483.88%
DAFNA Capital Management LLC 135,212$12,067,6713.30%
ARS Investment Partners, LLC 289,860$25,870,0053.02%
Ghost Tree Capital, LLC 100,000$8,925,0002.95%
View complete list of ASCENDIS PHARMA A/S shareholders